21ьз╕ C

Emerging Markets Report: Breakthroughs & Bureaucracy

News Provided by GlobeNewswire2025-02-12

Potential Regulatory Changes and an Epic Breakthrough in the Lab Bode Well for Hypha Labs and the Magic of the Mushroom

An Emerging Markets Sponsored Commentary

ORLANDO, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Not sure Hypha Labs (OTCQB: FUNI) could have had a better week than it did last week.

Imagine if Tesla got news that more states were going to look to mandate electric cars, greatly widening the EV company’s market opportunity.

Now, imagine if Tesla’s engineers said they had a breakthrough in the laboratory and now their electric batteries can go five times as far on one charge.

That hypothetical aside, this is the kind of week Hypha Labs just had.

First, Hypha isn’t exactly the kind of Company that pushes news out every week, feeding the market faint reminders that they exist. Two releases in a week are unusual for the Company that is going to market with the first in-home and commercial device of its kind to produce the finest functional mushroom ingredients in eight days or so using a compact device that easily sits on a residential countertop.

You read that right. Hypha Labs enables a person in their home to make a wide array of mushroom ingredients and is producing a commercial unit to grow the good stuff at scale for Big Pharma, restaurateurs, food makers… anyone who wants to harness the magic of the mushroom.

Intrigued? A full investor deck is available here once you’re done reading this editorial.

Earlier in the week, Hypha dropped news acknowledging a significant movement to change laws and regulations around mushroom use. And while there is already a massive functional mushroom market (over $31 billion in 2024), regulatory changes could greatly widen the types of mushrooms that can be consumed which would A) add that mushroom revenue to the overall legal mushroom industry and B) highlight the overall mushroom benefits of mushroom consumption.

Read this article when you get a second and ask yourself if this sure doesn’t sound a lot like the early cannabis political changes that led to the massive legal cannabis industry we see today. Even still, growing cannabis at home was easily achievable for many people. It’s not the most difficult crop. There’s a reason they call it “weed.”

Growing quality functional mushroom ingredients is much more challenging and current processes like growing mushrooms in animal excrement don’t seem so well-suited for the kitchen counter. Hypha will not likely see the type of competition to grow mushroom products that cannabis devices did and do.

For some time we’ve hammered home the fact that we think that Hypha Lab’s elegant device is a game-changer, a revolutionary model in an industry that we see is rapidly growing and ascendant.

So when we see news that the R&D team at Hypha Labs had a breakthrough in the lab and now the yields for a home user in the brief eight-day grow cycle are up 500% it more than turns our heads.

We’re sorting through decades of being in American markets and searching for a time when a Company posted FIVE-HUNDRED-PERCENT gains in production. An example does not readily come to mind.

It’s a remarkable achievement and for us, it means that a device that is first of its kind in so many ways just got exponentially more appealing and productive, more compelling to purchase in the first place, and more likely to churn future product purchases vis-à-vis Hypha’s evergreen customer relationship with their razor/razor blade model wherein the customer must re-purchase the proprietary grow solutions from Hypha for each yield.

It was indeed a week of breakthroughs for the Las Vegas-based mushroom innovator, and perhaps, the beginning of the end of massive bureaucracy for the amazing mushroom.

More on Hypha here.
https://www.hyphalabs.com/#watch

We intend to cover Hypha Labs for the next couple of months at minimum and to closely track the development and execution of their business model.
If you see what we see, we suggest you add the ticker “FUNI” to your watchlist and take a moment to review the Company’s Investor Presentation at the following link:
www.hyphalabs.com/deck

About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at https://emergingmarketsconsulting.com/alerts/

Must Read OTC Markets/SEC policy on stock promotion and investor protection

Section 17(b) of the Securities Act of 1933 requires that any person who uses the mail to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive certain compensation in the future, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during, or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid $50,000 CUMULATIVE by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer.

For media inquiries, please contact Maggie Caraway at maggie@emergingmarketsconsulting.com

U.S. National Debt Clock

national debt